Nigerian manufacturers are now clear to set-up for the production of cheap testing kits for corona-virus. This is possible because Nigeria Centre for Disease Control (NCDC) has successfully validated the first phase of the viral Ribonucleic Acid (RNA) extraction.

The validation took place on Thursday in the laboratory of the National Biotechnology Development Agency (NABDA) in Abuja. The Director-General of NABDA, Prof. Alex Akpa, told the News Agency of Nigeria (NAN) after the exercise that the success of the validation was important not only to Nigeria but Africa as a whole.

“The success of this validation shall enable us to massively produce test kits so that more people would be tested for COVID-19, not only in Nigeria but in Africa.

“The immediate aim is to produce reagents for real time Polymerase Chain Reaction (PCR), and remember, recently the lack of reagents stalled work in Kano and molecular diagnosis could no longer take place,’’ Akpa said.

“This project is, therefore, designed to enable not only Nigeria but the whole of Africa to put the issue of shortage of reagents behind,’’ the Director-General added.